Publicaciones (19) Publicaciones de Esperanza Feijoo Blanco

2015

  1. Lipid nanoparticles for cyclosporine a administration: Development, characterization, and in vitro evaluation of their immunosuppression activity

    International Journal of Nanomedicine, Vol. 10, pp. 6541-6553

2013

  1. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/ transforming growth factor β-dependent mesenchymal-to-mesenchymal transition

    Arthritis and Rheumatism, Vol. 65, Núm. 1, pp. 258-269

2012

  1. GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides

    PLoS ONE, Vol. 7, Núm. 11

2011

  1. Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation

    PLoS ONE, Vol. 6, Núm. 3

  2. Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFβ1 in melanoma enhances tumor infiltration and immunosuppression

    Cancer Research, Vol. 71, Núm. 3, pp. 812-821

  3. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis

    Cytokine, Vol. 53, Núm. 3, pp. 327-333

2008

  1. Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury

    Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Núm. 1, pp. 9-18

2007

  1. Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library

    Cytokine, Vol. 39, Núm. 2, pp. 106-115

2005

  1. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8

    International Journal of Cancer, Vol. 116, Núm. 2, pp. 275-281

  2. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

2004

  1. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens

    International Journal of Cancer, Vol. 110, Núm. 1, pp. 51-60

  2. MAGE antigens: Therapeutic targets in hepatocellular carcinoma?

    Journal of Hepatology

2003

  1. Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death

    Clinical Cancer Research, Vol. 9, Núm. 10 I, pp. 3546-3554

2002

  1. Clinical implications of antigen transfer mechanisms from malignant to dendritic cells: Exploiting cross-priming

    Experimental Hematology, Vol. 30, Núm. 12, pp. 1355-1364

2001

  1. Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain)

    Human Immunology, Vol. 62, Núm. 8, pp. 821-825

1995

  1. Anti-CD4 activity in circulating immune complexes in HIV-infected patients

    International Archives of Allergy and Immunology, Vol. 106, Núm. 4, pp. 366-371

1994

  1. DNA content in non-hodgkin's lymphoma: Comparison between flow cytometry and cytogenetics in fresh and paraffin-embedded tissue

    Acta Oncologica, Vol. 33, Núm. 6, pp. 621-625

1993

  1. Levamisole and interferon in children with chronic hepatitis B

    Hepatology, Vol. 18, Núm. 2, pp. 264-269

1992

  1. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients

    Transplantation Proceedings